Grifols (GIKLY) Shares Outstanding (Diluted Average) (2010 - 2021)

Grifols (GIKLY) reported Shares Outstanding (Diluted Average) of $308.87 for Q4 2021, down 71.22% on a YoY basis from $1073.1 in Q4 2020, and down 71.22% quarter-over-quarter from $1073.1 in Q4 2020.

Grifols (GIKLY) Shares Outstanding (Diluted Average) (2010 - 2021) Analysis & Trends

Grifols has reported Shares Outstanding (Diluted Average) for 11 years, with the latest figure at $308.87 in Q4 2021.

  • For the quarter ending Q4 2021, Shares Outstanding (Diluted Average) fell 71.22% year-over-year to $308.87; the trailing twelve-month figure through Dec 2021 stood at $308.87 (down 71.22% YoY), and the FY2021 full-year result was $308.87, down 71.22% from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2021 stood at $308.87, down from $1073.1 in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $1.0 million in Q4 2019, with the low at $308.87 in Q4 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $201932.3 across 5 years, with a median of $560.92 in 2018.
  • Annual changes were most pronounced in 2018 — Shares Outstanding (Diluted Average) grew 24.42% — and 2020, when it sank 99.89%.
  • Grifols' Shares Outstanding (Diluted Average) stood at $450.82 in 2017, then grew by 24.42% to $560.92 in 2018, then jumped by 179474.59% to $1.0 million in 2019, then sank by 99.89% to $1073.1 in 2020, then plunged by 71.22% to $308.87 in 2021.
  • The last three Shares Outstanding (Diluted Average) figures came in at $308.87 (Q4 2021), $1073.1 (Q4 2020), and $1.0 million (Q4 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 895.90 Mn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 2.45 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 1.77 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 544.00 Mn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 1.25 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 5.73 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -
10 Grifols - - - -

Historic Data

Download Data
DateValue
Dec 31, 2021 308.87
Dec 31, 2020 1,073.06
Dec 31, 2019 1.01 Mn
Jun 30, 2018 560.92
Jun 30, 2017 450.82
Sep 30, 2016 658.55
Jun 30, 2016 440.65
Sep 30, 2015 656.25
Jun 30, 2015 41,995.37
Mar 31, 2015 429.34
Sep 30, 2013 1,046.78
Jun 30, 2013 705.11
Mar 31, 2013 356.50
Dec 31, 2012 972.67
Sep 30, 2012 725.35
Jun 30, 2012 501.13
Mar 31, 2012 262.26
Dec 31, 2011 215.63
Sep 30, 2011 254.63
Jun 30, 2011 129.46